thymine has been researched along with Brain Neoplasms in 6 studies
Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Diallyl disulfide is a redox-sensitive molecule involved in redox cell activities, and thymine is a uracil derivative and one of the well-known bioactive compounds that can enhance the pharmacological activity of doxorubicin." | 5.91 | Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells. ( Amerhanova, SK; Antipin, IS; Bakhtiozina, LR; Kadirov, MK; Lyubina, AP; Mansurova, EE; Nizameev, IR; Semenov, VE; Shulaeva, MM; Voloshina, AD; Ziganshina, AY, 2023) |
| "A two-year-old boy with a malignant tumor of the brain (medulloblastoma) excreted large amounts of thymine and uracil in his urine." | 3.66 | Urinary excretion of thymine and uracil in a two-year-old child with a malignant tumor of the brain. ( Berglund, G; Greter, J; Lindstedt, S; Steen, G; Waldenström, J; Wass, U, 1979) |
| "Diallyl disulfide is a redox-sensitive molecule involved in redox cell activities, and thymine is a uracil derivative and one of the well-known bioactive compounds that can enhance the pharmacological activity of doxorubicin." | 1.91 | Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells. ( Amerhanova, SK; Antipin, IS; Bakhtiozina, LR; Kadirov, MK; Lyubina, AP; Mansurova, EE; Nizameev, IR; Semenov, VE; Shulaeva, MM; Voloshina, AD; Ziganshina, AY, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ziganshina, AY | 1 |
| Mansurova, EE | 1 |
| Voloshina, AD | 1 |
| Lyubina, AP | 1 |
| Amerhanova, SK | 1 |
| Shulaeva, MM | 1 |
| Nizameev, IR | 1 |
| Kadirov, MK | 1 |
| Bakhtiozina, LR | 1 |
| Semenov, VE | 1 |
| Antipin, IS | 1 |
| Takano, J | 1 |
| Matsuhashi, N | 1 |
| Takahashi, T | 1 |
| Tanahashi, T | 1 |
| Matsui, S | 1 |
| Imai, H | 1 |
| Tanaka, Y | 1 |
| Yamaguchi, K | 1 |
| Yoshida, K | 1 |
| Hatanaka, H | 1 |
| Soloway, AH | 1 |
| Sweet, H | 1 |
| Samuels, LL | 1 |
| Straw, JA | 1 |
| Berglund, G | 1 |
| Greter, J | 1 |
| Lindstedt, S | 1 |
| Steen, G | 1 |
| Waldenström, J | 1 |
| Wass, U | 1 |
| Mundinger, F | 1 |
| Vogt, P | 1 |
| Jobski, C | 1 |
| Fischer, HU | 1 |
| Ostertag, C | 1 |
6 other studies available for thymine and Brain Neoplasms
| Article | Year |
|---|---|
Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells.
Topics: Antineoplastic Agents; Brain Neoplasms; Doxorubicin; Drug Carriers; Drug Delivery Systems; Glioblast | 2023 |
[A Case of Metastatic Colorectal Cancer with Brain Metastasis Treated with Combined TFTD and Bevacizumab Therapy].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Brain Neoplasms; Colonic Neoplasm | 2018 |
Incorporation of pyrimidines and boron analogues into brain tumour and brain tissue of mice. An approach to boron-neutron capture therapy.
Topics: Animals; Boron; Brain Neoplasms; Carbon Isotopes; DNA; Ependymoma; Mice; Neoplasms, Experimental; Ne | 1967 |
Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
Topics: Animals; Brain Neoplasms; Deoxycytidine; DNA Replication; Dose-Response Relationship, Drug; Hypoxant | 1984 |
Urinary excretion of thymine and uracil in a two-year-old child with a malignant tumor of the brain.
Topics: Adolescent; Brain Neoplasms; Child, Preschool; Female; Fibroblasts; Humans; Leukemia, Lymphoid; Male | 1979 |
[Clinical and experimental results of interstitial Brachy-Curie-therapy combined with radiation sensitizing agents in infiltrative growing brain neoplasms].
Topics: Animals; Brain Neoplasms; Bromodeoxyuridine; Carcinosarcoma; Cytidine; Fluorouracil; Guanosine; Irid | 1972 |